Latest respiratory and systemic diseases Stories

AUSTIN, Texas, May 16, 2012 /PRNewswire/ -- Respira Therapeutics, Inc. (http://www.respiratherapeutics.com), developer of a breakthrough, excipient-free, high efficiency, dry powder inhaler (DPI) drug delivery technology for the treatment of respiratory and systemic diseases, announced today that Armando Anido, former President & CEO of Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), was elected to the Respira Therapeutics, Inc. board of directors. Mr. Anido joined Auxilium...